What is GlycoMimetics Inc (GLYC) stock price today?

GlycoMimetics Inc (GLYC) currently trades at $0.16 per share. The stock has a market capitalization of $10.13M and a P/E ratio of —x.

Is GLYC stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, GlycoMimetics Inc has a Smart Value Score of 17/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is GlycoMimetics Inc's revenue and earnings?

GlycoMimetics Inc has trailing twelve-month (TTM) revenue of $10000.00 with profit margins of 0.00%. Earnings per share (EPS) is $-46.00.

GLYC

GlycoMimetics Inc

NASDAQ: GLYC · HEALTHCARE · BIOTECHNOLOGY

$0.16

+0.00% today

Updated 2026-04-30

Market cap

$10.13M

P/E ratio

—

P/S ratio

1,095.16x

EPS (TTM)

$-46.00

Dividend yield

—

52W range

$0 – $18

Volume

—

Market cap

$10.13M

P/E ratio

—

P/S ratio

1,095.16x

EPS (TTM)

$-46.00

Dividend yield

—

52W range

$0 – $18

Volume

—

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

3.7

Growth

5.0

Quality

C+

3.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$1.00

+536.94%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-5.11B

- Revenue declining -100.00% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2021	2022	2023	2024	TTM
Revenue	$1.16M	$74925.00	$10000.00	$0.00	$10000.00
Net income	$-63.14M	$-93.33M	$-36.90M	$-37.88M	$-2.34M
EPS	—	—	—	—	$-46.00
Free cash flow	$-57.50M	$-46.54M	$-34.90M	$-31.11M	$-5.11B
Profit margin	-5,443.31%	-124,562.69%	-368,994.20%	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
GLYC	$10.13M	17	3.7	3.0	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

GlycoMimetics Inc trades at $0.16. Our Smart Value Score of 17/100 indicates the stock is weak. TTM revenue stands at $10000.00.

Frequently asked questions

What is GlycoMimetics Inc's stock price?

GlycoMimetics Inc (GLYC) trades at $0.16.

Is GlycoMimetics Inc overvalued?

Smart Value Score 17/100 (Grade F, Strong Sell).

What is the price target of GlycoMimetics Inc (GLYC)?

The analyst target price is $1.00, representing +536.9% upside from the current price of $0.16.

What is GlycoMimetics Inc's revenue?

TTM revenue is $10000.00.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio1,095.16x

ROE-182.70%

Beta1.60

50D MA$22.49

200D MA$24.90

Shares out0.06B

Float0.00B

Short ratio—

Avg volume—

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

GLYC vs LLY →GLYC vs JNJ →GLYC vs ABBV →Stock screener →